sotalol has been researched along with Benign Neoplasms in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the risk associations disappeared in long-term use and were modified by background co-morbidities." | 1.48 | Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men. ( Auvinen, A; Kaapu, KJ; Murtola, TJ; Rantaniemi, L; Taari, K; Talala, K; Tammela, TLJ, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaapu, KJ | 1 |
| Rantaniemi, L | 1 |
| Talala, K | 1 |
| Taari, K | 1 |
| Tammela, TLJ | 1 |
| Auvinen, A | 1 |
| Murtola, TJ | 1 |
1 other study available for sotalol and Benign Neoplasms
| Article | Year |
|---|---|
Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men.
Topics: Aged; Anti-Arrhythmia Agents; Databases, Factual; Digoxin; Finland; Humans; Male; Middle Aged; Neopl | 2018 |